SCHULER JACK W

SEC source: 0001144204-18-059275 · tv507084_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,610,923

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.71 to $15.56, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Schuler Family Foundation (the "Foundation"). Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, this Form 4 is a voluntary report with respect to these purchases of the Issuer's common stock by the Foundation.

SEC source: 0000905148-18-000587 · form4.xml · derivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 3,961,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 21, 2018, as a result of receipt of the Requisite Stockholder Approval (defined and described further in the reporting person's amendment to Schedule 13D filed on April 19, 2018), each share of Series B Convertible Preferred Stock ("Preferred Stock") automatically converted into 100 shares of Common Stock, reflecting a conversion price equal to $1.00 per share.

F2 · derivative.expiration_date: The Preferred Stock had no expiration date.

F3 · ownership.nature: These shares of Common Stock ("Shares") and Preferred Stock are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

SEC source: 0000905148-18-000587 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 17,378,242

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On June 21, 2018, as a result of receipt of the Requisite Stockholder Approval (defined and described further in the reporting person's amendment to Schedule 13D filed on April 19, 2018), each share of Series B Convertible Preferred Stock ("Preferred Stock") automatically converted into 100 shares of Common Stock, reflecting a conversion price equal to $1.00 per share.

F3 · ownership.nature: These shares of Common Stock ("Shares") and Preferred Stock are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

SEC source: 0001144204-18-029491 · tv494321_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,340,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.95 to $20.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F5 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001209191-18-031226 · doc4.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,661

Underlying: Common Stock · 1,661 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common Stock.

F4 · derivative.exercise_date: The restricted stock units vest on May 15, 2019.

F4 · derivative.expiration_date: The restricted stock units vest on May 15, 2019.

SEC source: 0001209191-18-031226 · doc4.xml · derivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

Underlying: Common Stock · 200 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common Stock.

F2 · shares: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F4 · derivative.exercise_date: The restricted stock units vest on May 15, 2019.

F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F4 · derivative.expiration_date: The restricted stock units vest on May 15, 2019.

SEC source: 0001209191-18-031226 · doc4.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667

Underlying: Common Stock · 667 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common Stock.

F2 · shares: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F3 · derivative.exercise_date: The restricted stock units vest on the date of grant, May 15, 2018.

F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.

F3 · derivative.expiration_date: The restricted stock units vest on the date of grant, May 15, 2018.

SEC source: 0001144204-18-029179 · tv494316_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,330,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.85 to $20.05, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F5 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-18-028936 · tv494278_4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,265,028

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.65 to $20.00, inclusive.

F7 · balance_after: Shares previously disclosed as being owned by the Schuler Family Foundation (the "Foundation") have been omitted. The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Foundation. Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, for purposes of Section 16(b), the reporting person has never been and is not currently the beneficial owner of any securities held by the Foundation, including the Issuer's common stock, and the inadvertent reporting of transactions in the Issuer's securities by the Foundation on previous Form 4s filed by the reporting person should be disregarded.

F3 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-18-028936 · tv494278_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,242,828

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.55 to $19.45, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (2) to this Form 4.

F7 · balance_after: Shares previously disclosed as being owned by the Schuler Family Foundation (the "Foundation") have been omitted. The reporting person disclaims beneficial ownership of the shares of the Issuer owned by the Foundation. Although the reporting person is the President of the Foundation and makes investment decisions regarding the Foundation's securities transactions, by virtue of the Foundation's status as a 501(c)(3) tax-exempt organization, the reporting person may not, and in fact, does not personally derive any profit from the Foundation's transactions in the Issuer's common stock. As a result, for purposes of Section 16(b), the reporting person has never been and is not currently the beneficial owner of any securities held by the Foundation, including the Issuer's common stock, and the inadvertent reporting of transactions in the Issuer's securities by the Foundation on previous Form 4s filed by the reporting person should be disregarded.

F3 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001179110-18-006058 · edgar.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,078

Underlying: Common Stock · 170 shares

Expires not disclosed

F1 · derivative.exercise_date: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

F1 · derivative.expiration_date: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

SEC source: 0000905148-18-000454 · form4.xml · derivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 39,619

Underlying: Common Stock · 3,961,900 shares

Expires not disclosed

F2 · derivative.exercise_price: Each share of Preferred Stock is initially convertible into 100 Shares automatically upon the Requisite Stockholder Approval (defined and described further in the Schedule 13D/A filed by the Reporting Person on April 19, 2018), subject to customary anti-dilution adjustments, reflecting an initial conversion price equal to $1.00 per share. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: Each share of Preferred Stock is initially convertible into 100 Shares automatically upon the Requisite Stockholder Approval (defined and described further in the Schedule 13D/A filed by the Reporting Person on April 19, 2018), subject to customary anti-dilution adjustments, reflecting an initial conversion price equal to $1.00 per share. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: Each share of Preferred Stock is initially convertible into 100 Shares automatically upon the Requisite Stockholder Approval (defined and described further in the Schedule 13D/A filed by the Reporting Person on April 19, 2018), subject to customary anti-dilution adjustments, reflecting an initial conversion price equal to $1.00 per share. The Preferred Stock has no expiration date.

F1 · ownership.nature: These shares of Common Stock ("Shares") and Series B Convertible Preferred Stock ("Preferred Stock") are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

SEC source: 0000905148-18-000454 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 13,416,342

F1 · ownership.nature: These shares of Common Stock ("Shares") and Series B Convertible Preferred Stock ("Preferred Stock") are directly held by the Jack W. Schuler Living Trust. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

SEC source: 0001144204-18-018913 · tv490262_4.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,476

Underlying: Common Stock · 9,476 shares

Expires 2028-04-01

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2018.

SEC source: 0001144204-18-013311 · tv487924_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,530,423

F1 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F5 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-18-013030 · tv487901_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,530,323

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.45 to $25.30, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001692742-18-000044 · edgardoc.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 626,142

SEC source: 0001144204-18-012751 · tv487775_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,515,323

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.95 to $25.50, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-18-010826 · tv487128_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,165,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.00 to $25.40, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-18-010484 · tv486880_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,155,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.90 to $25.25, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-18-010232 · tv486791_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,145,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.80 to $25.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F7 · balance_after: Due to a clerical error, the total reported shares owned indirectly by the reporting person through the Jack W. Schuler Living Trust has been adjusted to correct an overstatement of total holdings by 44,670 shares first reflected in the reporting person's Form 4 filed on December 15, 2017.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001692742-18-000014 · edgardoc.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,908

Underlying: Common Stock · 132 shares

Expires not disclosed

F1 · derivative.exercise_date: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

F1 · derivative.expiration_date: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

SEC source: 0001209191-18-005286 · doc4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust & Other

Disclosed balance after: 3,414,053

F1 · price: The weighted average sale price for these transactions was $48.5026 per share, with a range of $48.00 to $49.02. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.

F2 · balance_after: The shares reported on this Form 4 as indirectly owned by the Reporting Person include 3,119,053 shares held indirectly by the Reporting Person's Trust, 65,000 shares held indirectly by the Reporting Person's spouse, and 230,000 shares held by The Schuler Grandchildren's LLC.

F3 · balance_after: In addition to the shares reported on this Form 4 as indirectly owned by the Reporting Person, 946,428 shares are held indirectly by the Schuler Family Foundation and 484,516 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by the Foundation and the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.

F2 · ownership.nature: The shares reported on this Form 4 as indirectly owned by the Reporting Person include 3,119,053 shares held indirectly by the Reporting Person's Trust, 65,000 shares held indirectly by the Reporting Person's spouse, and 230,000 shares held by The Schuler Grandchildren's LLC.

SEC source: 0001209191-18-003048 · doc4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Trust & Other

Disclosed balance after: 3,426,053

F1 · price: The weighted average sale price for these transactions was $47.02 per share, with a range of $47.00 to $47.58. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.

F2 · balance_after: The shares reported on this Form 4 as indirectly owned by the Reporting Person include 3,119,053 shares held indirectly by the Reporting Person's trust, 65,000 shares held indirectly by the Reporting Person's spouse, and 242,000 shares held by the Schuler Grandchildren's LLC. On prior Form 4s these shares were reported as directly owned and did not include the Reporting Person's spouse's shares; these changes to indirect ownership and to include the Reporting Person's spouse's shares were made to correct a clerical error.

F3 · balance_after: In addition to the shares reported on this Form 4 as indirectly owned by the Reporting Person, 1,006,428 shares are held indirectly by the Schuler Family Foundation and 523,524 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by the foundation and the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.

F2 · ownership.nature: The shares reported on this Form 4 as indirectly owned by the Reporting Person include 3,119,053 shares held indirectly by the Reporting Person's trust, 65,000 shares held indirectly by the Reporting Person's spouse, and 242,000 shares held by the Schuler Grandchildren's LLC. On prior Form 4s these shares were reported as directly owned and did not include the Reporting Person's spouse's shares; these changes to indirect ownership and to include the Reporting Person's spouse's shares were made to correct a clerical error.

SEC source: 0001209191-17-067149 · doc4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365,053

F2 · price: The weighted average sale price for these transactions was $46.00 per share, with a range of $46.00 to $46.02. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.

F3 · balance_after: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse, 1,053,628 shares are held indirectly by the Schuler Family Foundation and 523,524 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by his spouse, the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.

SEC source: 0001209191-17-067149 · doc4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,365,553

F1 · price: The weighted average sale price for these transactions was $44.40 per share, with a range of $43.00 to $46.00. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.

SEC source: 0001144204-19-029844 · tv523089_4.xml · derivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,366,838

Underlying: Common Stock · 1,906,744 shares

Expires 2022-12-21

F5 · shares: The reported warrants to acquire common stock were acquired by the Jack W. Schuler Living Trust.

F6 · balance_after: The reported warrants consist of the 2,217,002 warrants to acquire common stock owned by the Jack W. Schuler Living Trust and the 149,836 warrants to acquire common stock owned by the Schuler Family Foundation.

F7 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest in the reported warrants to acquire common stock through (i) the Jack W. Schuler Living Trust, as its trustee and beneficiary and (ii) the Schuler Family Foundation, as its president.

SEC source: 0001144204-19-029844 · tv523089_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,270,481

F1 · shares: The reported securities were acquired by the Jack W. Schuler Living Trust.

F2 · balance_after: The reported securities consist of the 2,285,721 shares of common stock owned by the Jack W. Schuler Living Trust, the 846 shares of common stock owned by the Renate Schuler Living Trust, and the 983,914 shares of common stock owned by the Schuler Family Foundation, in each case immediately following the 12/19/2017 acquisition of 1,906,744 shares of common stock by the Jack W. Schuler Living Trust.

F4 · ownership.nature: Jack W. Schuler has an indirect pecuniary interest the reported securities through (i) the Jack W. Schuler Living Trust, as its trustee and beneficiary, (ii) the Renate Schuler Living Trust, as the spouse of its trustee and beneficiary, and (iii) the Schuler Family Foundation, as its president.

SEC source: 0001144204-17-063960 · tv481533_4.xml · derivative · entry 7

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,181 shares

Expires 2026-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The stock option vested in 12 equal monthly installments, with the first installment vesting on May 1, 2016.

SEC source: 0001144204-17-063960 · tv481533_4.xml · derivative · entry 6

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 44,670 shares

Expires 2023-04-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock option vested in 12 equal monthly installments, with the first installment vesting on May 3, 2013.

SEC source: 0001144204-17-063960 · tv481533_4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,169,698

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 52,851 shares issued to the reporting person upon exercise by the reporting person of the options reported herein, which shares were transferred to the Jack W. Schuler Living Trust and are held indirectly by the reporting person through the Jack W. Schuler Living Trust.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-063960 · tv481533_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 13,116,847

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 52,851 shares issued to the reporting person upon exercise by the reporting person of the options reported herein, which shares were transferred to the Jack W. Schuler Living Trust and are held indirectly by the reporting person through the Jack W. Schuler Living Trust.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001209191-17-065781 · doc4.xml · derivative · entry 9

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,021 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · derivative · entry 8

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,021 shares

Expires 2025-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · derivative · entry 7

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,041 shares

Expires 2024-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · derivative · entry 6

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,081 shares

Expires 2023-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · nonDerivative · entry 5

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,369,053

F1 · balance_after: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse, 1,066,428 shares are held indirectly by the Schuler Family Foundation and 523,524 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by his spouse, the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.

SEC source: 0001209191-17-065781 · doc4.xml · nonDerivative · entry 4

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,385,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · nonDerivative · entry 3

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,378,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,371,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-065781 · doc4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,362,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001144204-17-060115 · tv479937_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,500,323

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.50 to $22.45 inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-060015 · tv479842_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,494,823

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.05 to $21.25 inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-059684 · tv479739_4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,484,823

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.73 to $20.88 inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F7 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-059684 · tv479739_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,474,823

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.90 to $19.30 inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F7 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-059379 · tv479572_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,464,823

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.55 to $19.18 inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-058934 · tv479422_4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,444,823

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.60 to $19.00 inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F7 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-058934 · tv479422_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,420,242

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.35 to $18.70, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F7 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-058302 · tv479152_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,393,642

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.20 to $18.80, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-17-057664 · tv479097_4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Schuler Family Foundation

Disclosed balance after: 1,343,642

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.58 to $18.75, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Mr. Schuler has sole voting and dispositive power with respect to such shares in his capacity as President of the Schuler Family Foundation.

F6 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.